Publication details

Léčba chronické lymfocytární leukemie

Title in English Treatment of chronic lymphocytic leukaemia
Authors

DOUBEK Michael PANOVSKÁ Anna

Year of publication 2012
Type Article in Periodical
Magazine / Source Farmakoterapie
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords chronic lymphocytic leukaemia; prognostic factors; chemoimmunotherapy; allogeneic stem cell transplantation
Description The management of chronic lymphocytic leukaemia (CLL) has evolved dramatically in the last decade. Considerable efforts are focusing on better patient selection and treatment response prediction. Clinical intervention has been shown to alter the natural history of the disease. First-line therapy with FCR (fludarabine + cyclophosphamide + rituximab) regimen prolongs overall survival of CLL patients. Besides, many new agents are being evaluated on their own and in combination therapy in early and late phases of clinical studies. Here, we provide a general clinical introduction into CLL including diagnostics and prognostic markers followed by an overview of the current state-of-the-art treatment.

You are running an old browser version. We recommend updating your browser to its latest version.

More info